131.91
1.70%
+2.20
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DXCM?
Forum
Prognose
Aktiensplit
Finanzdaten der Dexcom Inc-Aktie (DXCM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
6.10%
1,034.50
|
975.00 | 871.30 | 741.50 | 815.20 |
Cost Of Revenue |
7.45%
377.90
|
351.70 | 324.90 | 278.90 | 273.90 |
Gross Profit |
5.34%
656.60
|
623.30 | 546.40 | 462.60 | 541.30 |
Operating Expenses
|
5.24%
439.70
|
417.80 | 418.30 | 415.40 | 415.90 |
Interest Income/Expense |
0.00%
4.90
|
4.90 | 5.90 | 4.60 | 4.70 |
Benefits Costs and Expenses |
7.31%
788.30
|
734.60 | 712.00 | 677.00 | 682.00 |
Costs And Expenses |
7.31%
788.30
|
734.60 | 712.00 | 677.00 | 682.00 |
Operating Income/Loss |
5.55%
216.90
|
205.50 | 128.10 | 47.20 | 125.40 |
Income/Loss From Continuing Operations Before Tax |
2.41%
246.20
|
240.40 | 159.30 | 64.50 | 133.20 |
Income Tax Expense/Benefit, Deferred |
195.88%
81.50
|
-85.00 | -42.20 | -9.30 | 32.00 |
Income Tax Expense/Benefit |
108.44%
-10.10
|
119.70 | 43.40 | 15.90 | 41.40 |
Income/Loss From Continuing Operations After Tax |
112.34%
256.30
|
120.70 | 115.90 | 48.60 | 91.80 |
Net Income/Loss
|
112.34%
256.30
|
120.70 | 115.90 | 48.60 | 91.80 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
100.18%
-0.70
|
386.60 | 386.70 | 386.70 | -1.00 |
Diluted Average Shares |
100.66%
-2.80
|
426.80 | 431.50 | 418.50 | -0.50 |
Basic Earnings Per Share |
112.90%
0.66
|
0.31 | 0.30 | 0.13 | 0.24 |
Diluted Earnings Per Share |
110.34%
0.61
|
0.29 | 0.28 | 0.12 | 0.22 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):